How to Enable Seamless Collaboration to Speed Up Rational Drug Discovery in Pharma & Biotech?
Despite numerous new technologies for drug design and discovery, the average number of FDA small-molecule drug approvals has unfortunately remained flat over the period of two decades.
One of the weaknesses is the ineffective communication between multi-faceted teams in the early stages of discovery, which is to some extent caused by the lack of common tools to exchange scientific information, including protein structure data.
On top of that, remote work makes the free flow of structural information even more challenging. Such an asynchronous way of working then leads to a lack of structural insights which can hinder the decision-making and favor “wrong” compound.
To further a multidisciplinary approach in pharma R&D, IT and drug design experts are coming together to develop new strategies with more collaborative tools that will reduce barriers of seamless knowledge exchange and improve project management.
Research Needs Collaboration
3decision is a modern software solution with collaborative technology for optimized teamwork and visual communication that easily integrates into the existing IT landscape. It allows pharma businesses to respond quickly to collaboration-shift and leverage rational drug design.
The Collaboration-Focused Structure of 3decision® Allows You to:
Break down silos between various departments and bring structural data to non-experts to improve collective knowledge and efficiency
Connect through a centralized platform from any location to enhance cross-team communication and collaboration in real-time
Reduce the risks of making wrong decisions and spending time on making “unfavorable” drugs due to inefficient project management
The empowerment of data-driven decision making in pharma R&D to speed up the development of next-generation drugs is our mission at Discngine! During 15 years of experience, Discngine has developed effective digital solutions to streamline the early drug design processes and accelerate drug discovery.
Our Mission
Discngine is a Winner of 2019 Bio-IT World Innovative Practices Awards together with Abbvie for the co-development of 3decision®
“We were sitting on these almost 9,000 structures, and except for 2-3 people, nobody else knew where they were.”
- Rishi Gupta, Senior Research Scientist at Abbvie
“The 3decision® site has become a key stopping point for our scientists who design compounds, analyze and share protein structures, and retrieve external and internal protein x-ray and NMR structures.”
- Research Fellow, Discovery Chemistry at Abbvie
